Skip to main content
ENTA logo
ENTA
(NASDAQ)
Enanta Pharmaceuticals, Inc.
$13.50-- (--)
Loading... - Market loading

Enanta Pharmaceuticals (ENTA) Stock Price & Financial Analysis

Enanta Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.43 - $13.91
52-Week High$17.15
52-Week Low$7.05
Open$13.91
Volume157.94K
Average Volume (3M)213.93K
Market Cap301.03M
Shares Outstanding21.38M
Price to Sales (P/S)4.35
Price to Book (P/B)2.58
EV/EBITDA-6.95
Revenue (TTM)69.21M
Net Income (TTM)-61.98M
Free Cash Flow (TTM)-9.61M
EPS (TTM)$-2.67
Profit Margin-89.56%
Operating Margin-87.24%
Return on Equity (ROE)-53.17%
Debt to Equity0.75
50-Day MA$13.57
200-Day MA$13.62
52-Week Change51.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Enanta Pharmaceuticals

What is the current stock price for ENTA?

As of the latest trading session, ENTA stock trades at $13.50. The 52-week range is $7.05–$17.15, with a day range of $13.43–$13.91.

What is the P/E ratio for ENTA?

The P/E ratio (Price-to-Earnings) for ENTA is shown in the Key Statistics section. This valuation metric helps compare Enanta Pharmaceuticals, Inc. to industry peers.

Does ENTA pay dividends?

Enanta Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ENTA?

Based on 1 analyst, the consensus for ENTA is Hold.

What is the market cap of ENTA?

Enanta Pharmaceuticals's market capitalization is $288.6M, classifying it as a micro-cap company. Enanta Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.